BTR Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$769K Hold
2,378
0.12% 92
2022
Q2
$771K Sell
2,378
-40
-2% -$12K 0.11% 94
2022
Q1
$692K Hold
2,418
0.09% 106
2021
Q4
$668K Hold
2,418
0.08% 109
2021
Q3
$559K Hold
2,418
0.07% 114
2021
Q2
$555K Sell
2,418
-100
-4% -$20.1K 0.07% 112
2021
Q1
$470K Hold
2,518
0.07% 116
2020
Q4
$425K Buy
2,518
+41
+2% +$6.12K 0.07% 117
2020
Q3
$367K Hold
2,477
0.06% 116
2020
Q2
$407K Sell
2,477
-25
-1% -$3.84K 0.08% 114
2020
Q1
$347K Sell
2,502
-40
-2% -$5.5K 0.08% 115
2019
Q4
$334K Hold
2,542
0.06% 129
2019
Q3
$284K Hold
2,542
0.05% 134
2019
Q2
$282K Sell
2,542
-871
-26% -$103K 0.05% 136
2019
Q1
$443K Sell
3,413
-19
-0.6% -$2.31K 0.09% 111
2018
Q4
$397K Hold
3,432
0.08% 118
2018
Q3
$368K Buy
+3,432
New +$343K 0.06% 123

Other funds holding LLY

BTR Capital Management's LLY Position: Q3 2022 in Review

BTR Capital Management held its Eli Lilly (LLY) position steady in Q3 2022 at 2,378 shares worth $769K. The position accounts for 0.12% of the portfolio, ranked #92.

BTR Capital Management first reported a position in LLY in Q3 2018 and has held it in 17 quarters since. The position peaked at $771K in Q2 2022. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • BTR Capital Management held 2,378 shares of Eli Lilly worth $769K as of Q3 2022.
  • BTR Capital Management left its Eli Lilly share count unchanged in Q3 2022.
  • Eli Lilly made up 0.12% of BTR Capital Management's portfolio in Q3 2022, its #92 holding.
  • BTR Capital Management first reported a position in Eli Lilly in Q3 2018 and has held it in 17 quarters since.
  • BTR Capital Management's Eli Lilly position peaked at $771K in Q2 2022.
  • 2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.